Solius: Funding, Investors & Team (Nov 2026)
Solius is a new technology to help vitamin D deficient Canadian for human health. The company is designed to harness the healing powers of the sun to stimulate the production of vitamin D without the harmful UVA rays or issues related to supplements. They provide the benefits of the sun without the harmful rays to unlock the healing powers of the human body, improving physical, mental, and immune function. Solius stimulates the body’s production of hormones and peptides critical to many aspects of health and wellbeing. Every element of SOLIUS has been designed to enhance the user experience and set a new standard for medical devices everywhere. Solius also developed an ultraviolet light system to help treat COVID-19. Solius was founded in 2011 and is headquartered in Bainbridge Island, Washington, United States.
Solius has raised $3.5M across 1 funding round on record, the most recent an undisclosed round of $3.5M announced in May 2026.
That round is below the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Solius Company Profile and Key Stats
Latest funding round on record: May 2026.
Solius Funding Rounds
Solius Founders and Leadership Team
Contact details for the Solius team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Solius Funding Compared to Other Biotechnology Startups
Solius' latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Solius in Biotechnology and Bainbridge Island
Companies Similar to Solius
Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…
Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.
Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality…
Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting…
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…
Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…
Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…
100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…
MEND is a company focused on life sciences, determined to assist individuals in achieving better health…
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Solius Funding FAQs
What does Solius do?
Solius is a new technology to help vitamin D deficient Canadian for human health. The company is designed to harness the healing powers of the sun to stimulate the production of vitamin D without the harmful UVA rays or issues related to supplements. They provide the benefits of the sun without the harmful rays to unlock the healing powers of the human body, improving physical, mental, and immune function. Solius stimulates the body’s production of hormones and peptides critical to many aspects of health and wellbeing. Every element of SOLIUS has been designed to enhance the user experience and set a new standard for medical devices everywhere. Solius also developed an ultraviolet light system to help treat COVID-19. Solius was founded in 2011 and is headquartered in Bainbridge Island, Washington, United States.
How much funding has Solius raised?
Solius has raised $3.5M across 1 round on record. The most recent is an undisclosed round of $3.5M announced in May 2026.
When did Solius last raise funding?
Solius' most recent funding round on record is an undisclosed round of $3.5M, announced in May 2026.
Who founded Solius?
FundedIQ lists Christopher Kiple (Founder) at Solius.
Where is Solius headquartered?
Solius is based in Bainbridge Island, Washington, United States.
How many employees does Solius have?
Solius is in the 11-50 employee band.
How does Solius' funding compare to other Biotechnology startups?
Solius' latest round of $3.5M is below the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's Solius Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Solius is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.